MHS
CAPR icon

M Holdings Securities’s Capricor Therapeutics CAPR Stock Holding History

M Holdings Securities’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-20,000
Closed -$94K – 265
2021
Q1 		$94K Buy
+20,000
New +$115K 0.01% 484

Other funds holding CAPR

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

M Holdings Securities's CAPR Position: Q2 2021 in Review

M Holdings Securities sold out of Capricor Therapeutics (CAPR) in Q2 2021, closing a stake of 20,000 shares — an estimated $94K sold.

M Holdings Securities first reported a position in CAPR in Q1 2021 and held it in 1 quarter. The position peaked at $94K in Q1 2021. 31 funds tracked by Wall St. Rank hold CAPR as of Q2 2021.

  • M Holdings Securities reported no remaining Capricor Therapeutics position as of Q2 2021 after selling out during the quarter.
  • M Holdings Securities sold 20,000 Capricor Therapeutics shares in Q2 2021, an estimated $94K.
  • M Holdings Securities first reported a position in Capricor Therapeutics in Q1 2021 and held it in 1 quarter.
  • M Holdings Securities's Capricor Therapeutics position peaked at $94K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2021.

Based on M Holdings Securities's 13F filing for Q2 2021, filed 19 Aug 2021.